Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.